231 related articles for article (PubMed ID: 17071141)
1. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
Ettinger AB; Kustra RP; Hammer AE
Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
[TBL] [Abstract][Full Text] [Related]
5. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
[TBL] [Abstract][Full Text] [Related]
6. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
Fakhoury TA; Miller JM; Hammer AE; Vuong A
Drugs Aging; 2008; 25(11):955-62. PubMed ID: 18947263
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
Sunder TR; McKee JR; Hammer AE; Vuongc A
Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
9. [Mood States in outpatients with lesional epilepsy at the neurosurgical clinic and improvement in mood States after lamotrigine addiction].
Kajita Y; Yoshida K; Nagai T; Wakabayashi T
No Shinkei Geka; 2013 Mar; 41(3):209-18. PubMed ID: 23459518
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine in patients with epilepsy and comorbid depressive symptoms.
Fakhoury TA; Barry JJ; Mitchell Miller J; Hammer AE; Vuong A
Epilepsy Behav; 2007 Feb; 10(1):155-62. PubMed ID: 17166775
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate.
Edwards KR; Sackellares JC; Vuong A; Hammer AE; Barrett PS
Epilepsy Behav; 2001 Feb; 2(1):28-36. PubMed ID: 12609179
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
[TBL] [Abstract][Full Text] [Related]
17. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
Chang JS; Moon E; Cha B; Ha K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
[TBL] [Abstract][Full Text] [Related]
19. Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.
Griffith NM; Szaflarski JP; Szaflarski M; Kent GP; Schefft BK; Howe SR; Privitera MD
Epilepsy Behav; 2005 Sep; 7(2):266-72. PubMed ID: 16005686
[TBL] [Abstract][Full Text] [Related]
20. Improved mood states with lamotrigine in patients with epilepsy.
Cramer JA; Hammer AE; Kustra RP
Epilepsy Behav; 2004 Oct; 5(5):702-7. PubMed ID: 15380122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
